Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation Aggression in Dementia”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Study completedNCT00145691
What this trial is testing

The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)

Who this might be right for
Agitation Aggression in Dementia
Sykehuset Innlandet HF 100
Testing effectiveness (Phase 2)Ended earlyNCT02992132
What this trial is testing

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Who this might be right for
Agitation and Aggression in Alzheimer's Disease
ACADIA Pharmaceuticals Inc. 111
Testing effectiveness (Phase 2)Study completedNCT03375671
What this trial is testing

Rapid Agitation Control With Ketamine in the Emergency Department

Who this might be right for
Violent Aggressive BehaviorKetamine
David Barbic 81
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Not applicableStudy completedNCT01485692
What this trial is testing

Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation

Who this might be right for
Psychomotor Agitation
University of Sao Paulo 120
Testing effectiveness (Phase 2)Study completedNCT02129348
What this trial is testing

Treatment of Psychosis and Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePsychosisAgitation
New York State Psychiatric Institute 77
Post-approval studies (Phase 4)UnknownNCT00986167
What this trial is testing

Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry

Who this might be right for
SchizophreniaPsychosis
Bayside Health 72
Not applicableActive Not RecruitingNCT04829500
What this trial is testing

Effectiveness and Implementation of Montessori Approaches in Person-Centered Care Within VA

Who this might be right for
Dementia or a Related DisorderMental Health DiagnosesSymptoms of Agitation or Aggression
VA Office of Research and Development 356
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07328529
What this trial is testing

Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome

Who this might be right for
Aggressive Behavior in Fragile X Syndome
Azevan Pharmaceuticals 80
Large-scale testing (Phase 3)Study completedNCT00455234
What this trial is testing

Rapid Tranquillization Trial: TREC-India II

Who this might be right for
Psychotic DisordersAggression
Christian Medical College, Vellore, India 300
Not applicableStudy completedNCT01856010
What this trial is testing

Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia

Who this might be right for
DementiaAggressionAgitation
Pine Rest Christian Mental Health Services 23
Testing effectiveness (Phase 2)Study completedNCT03118947
What this trial is testing

Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Who this might be right for
Agitation and Aggression in Alzheimer's Disease
ACADIA Pharmaceuticals Inc. 79
Testing effectiveness (Phase 2)Study completedNCT00073658
What this trial is testing

Treating Behavioral Disturbances in Individuals With Dementia

Who this might be right for
Dementia
University of Pittsburgh 137
Early research (Phase 1)Study completedNCT05227118
What this trial is testing

MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 29
Post-approval studies (Phase 4)Study completedNCT00401167
What this trial is testing

Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 31
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Post-approval studies (Phase 4)Study completedNCT03639558
What this trial is testing

TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting

Who this might be right for
Psychiatric EmergencyAggressionAgitation
Joseph Dib 100
Post-approval studies (Phase 4)Study completedNCT01050478
What this trial is testing

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Who this might be right for
Psychomotor AgitationAcute Disease
Janssen Cilag N.V./S.A. 56
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Load More Results